Health Technology Assessment Archives -

Scotland backs AZ’s Lynparza for first-line ovarian cancer maintenance

https://pharmaphorum.com/news/scotland-backs-azs-lynparza-for-first-line-ovarian-cancer-maintenance/

Division on European HTA

https://pharmaphorum.com/views-and-analysis/hta-european-health-technology-assessment-division-progress/

Industry urges EU to scrap national HTA bodies

https://pharmaphorum.com/news/industry-urges-eu-to-scrap-national-hta-bodies/

Resourcing HTA across Europe

https://pharmaphorum.com/views-analysis-market-access/resourcing-hta-across-europe/

Harmonised health technology assessment in Europe? There’s a long way to go

https://pharmaphorum.com/views-analysis-market-access/harmonised-health-technology-assessment-in-europe-theres-a-long-way-to-go/

Is Europe ready for a single health technology assessment?

https://pharmaphorum.com/views-and-analysis/europe-hta-harmonisation/

Mind the (implementation) gap

https://pharmaphorum.com/views-and-analysis/hta-impact-implementation-gap/

Orphan drugs: overcoming HTA barriers to access

https://pharmaphorum.com/views-and-analysis/orphan-drugs-overcoming-hta-barriers-access/

10/03/2017

Approval and access: overcoming the final hurdle of drug development

https://pharmaphorum.com/debates-insight-market-access/european-market-access-overcoming-final-hurdle-drug-development/

Search